Miromatrix Medical Stock
Biological human organ development
Sign up today and learn more about Miromatrix Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Miromatrix Medical Stock
Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care. The company was founded in 2009 and is based in Eden Prairie, Minnesota.
President and CEO
Jeff Ross, Ph.D
Vice-President of Research and Development
Thomas Gilbert, Ph.D